Drupal.behaviors.print = function(context) {window.print();window.close();}>
Response Biomedical Regains Rights to Flu, RSV Tests after Termination of 3M Deal
October 03, 2012
Response Biomedical Regains Rights to Flu, RSV Tests after Termination of 3M Deal
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
FDA Clears Focus Diagnostics' Flu Test on 3M Integrated Cycler
October 9, 2012 / GenomeWeb Daily News
Life Technologies to Distribute Quidel MDx Assays
September 22, 2011 / GenomeWeb Daily News
Roche Diagnostics Terminates Deal to Market Response Bio's Cardiovascular Panel
September 2, 2011 / GenomeWeb Daily News
Response Biomedical Gets FDA OK for H1N1 Reactivity Info in Assay Package Insert
October 22, 2009 / GenomeWeb Daily News
NMT Reassures GenMark Following Luminex Deal; GenMark Continuing Diligence
June 13, 2013 / GenomeWeb Daily News